1[1]Klagsbrum, M, Sorer S. VEGF/VPF. The angiogenesis factor found? Curr Biol, 1993.3:699.
2[2]O'Brien T, Cranston D. Bladder cancer, in Morris P, Malt R(eds)"Oxford Textbook of Surery. Oxford, Oxford University Press, 1994,12:1608.
3[3]Crew JP, O' Brien T, Bicknell R, et al. Urinary vascular endothelial growth factor and its correlation with bladder cancer recurrence rates. J Urol, 1999,161: 799-804.
4[4]O' Brien TS, Cranston D, Fuggle S, et al. Different angiogenic pathways characterize superficial and invasive bladder. cancer. Cancer Res, 1995,55:510.
5[5]Crow JP, O' Brien TS, Bradbum M, et al. Vascular endothelial growth factor is a predictor of relapse and stage progression in superficial bladder cancer. Cancer Res, 1997,57:5281.
6[6]Mukhopadhyay D, Tsiokas L, Sukhatme VP. Wild-type p53 and v-SRC exert opposing influences on human vascular endothelial growth factor gene expression. Oncogen, 1994,9:963.
7[7]Ikeda E, Achen MG, Breier G, et al. Hypoxia induced transcriptional activation and increased mRNA stability of vascular endothelial growth factor in C6 glima cells. J Biol Chem, 1995,270:19761.
8[8]Carmeliet liet P, Dor Y,Herbert J- M.et al. Role of HIF-1α in hypoxia mediated apoptosis,cell proliferation and tumour angiogenesis. Nature, 1998,394:485.
9[9]Rishimatsu A,Narko K, Enholm B,et al. Proinflammatory cytokines regulate expression of the lymphatic endothelial mitogen VEGF-C.J Biol Chem, 1998,273: 8413.
10[10]Chodak G, Scheiner C, Zetter B. Urine from patients with transitional cell carcinoma stimulates migration of capillary endothelial cells. N Engl J Med,1981,305:869.
同被引文献14
1Tung-Ping RR, Fan ST, Wong J. Risk factors, prevention and management of postoperative recurrence after resection of hepatocellular carcinoma[J]. Ann Surg,2000,32(1):10-24.
2Yancopoulos GD,Davis S,Gale NW et al. Vascularspecific growth factors and blood vessel formation[J]. Nature,2000,407(6801) : 242-248.
4Tomisaki S,Ohno S, Ichiyoshi Yet al. Microvessel quantification and its possible relation with liver metastasis in colorectal cancer[J]. Cancer, 1996,77 (8Suppl) : 1722-1728.
5Edgren M, Lennernas B, Larsson A et al. Serum concentration of VEGF and bFGF in renal cell,prostate and urinary bladder carcinomas[J]. Anticancer Res,1999,19(1B):869-873.
6OtBrien T,Cranston D,Fuggle Set al. Two mechanisms of basic fibroblast growth factor induced angiogenesis in bladder cancer[J]. Cancer Res, 1997,57(1): 136-140.
7Miyake H,Hara I,Yamanaka K et al. Elevation of serum level of vascular endothelial growth factor as a new predictor of recurrence and disease progression in patients with superficial urothelial cancer [J].Urology, 1999,53 (2): 302-307.
8Teo NB,Shoker BS, Martin L, et al. Angiogenesis in pre-invasive cancers[J]. Anticancer Res, 2002, 22(4):2061-2072.
9Agnayo A, Kantarjian HM, Estegy EH,et al. Plasma vascular endothelial growth factor levels have prognostic significance in patients with acute myeloid leukemia but not in patients with myelodysplastic syndromes[J]. Cancer, 2002, 95(9):1923-1930.
10Thaloor D, Singh AK.Sidhu GS,et al. Inhibition of angiogenic differentiation of human umbilical vein endothelial cells by curcumin[J]. Cell Growth Differ, 1998,9(4):305-312.
